))
Hypercoagulation and Persistent Microclots in Long COVID
Manage episode 424369027 series 3557192
Content provided by Gordon Medical Associates. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Gordon Medical Associates or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Hypercoagulation and persistent microclots represent another component to explore as we study complex chronic illness. Long COVID has brought this issue into the limelight and has intensified the research into this issue.
Hypercoagulation has been suspected of contributing to autoimmune disorders, Lyme Disease, ME/CFS, and fibromyalgia. Dr. Jordan Vaughn has brought the work of Dr. Pretorius and Dr. Kell on Long Covid and hypercoagulation to the chronic disease community in the USA.
Dr. Eric Gordon sits down with Dr. Jordan Vaughn to discuss his research, testing, and how to begin to promote recovery.
Episode highlights include:
- COVID-associated coagulopathy, how COVID makes the coagulation system respond in a very different way
- Benefits of fluorescent microscopy for detecting blood abnormalities
- The tendency of patients with ME/CFS and fibromyalgia to hypercoagulate
- What Dr. Vaughn has found to be the most helpful in an attempt to help the body break down persistent microclots
- Thrombo-inflammation: thrombosis and inflammation of superficial veins
- Impact of venous pooling and insufficiency
- How to address POTS and lower-extremity pain
- Research on blood clotting and spike protein
Listen in to learn more :
(00:02) Exploring Hypercoagulability and Microclots
(09:06) Understanding Structural Factors in Clot Formation
(13:57) Exploring Venous System Dysfunction and Treatment
(26:08) Exploring Morning Venous Blood Stasis
(32:02) Imaging and Treating Venous Dysfunction
About Jordan Vaughn MD, ABI
As owner and CEO of MedHelp, Dr. Vaughn has directed his organization to the leading edge of early outpatient treatment of COVID-19 for his patients and the greater Birmingham community.
Dr. Vaughn's treatment protocols are driven by understanding the spike protein's ability to cause endothelial damage and clotting in the microcapillaries. He also uses immunofluorescent microscopy to diagnose the presence of amyloid fibrin in the blood. Dr. Vaughn is the founder and president of the Microvascular Research Foundation and is a clinical collaborator alongside Dr. Jaco Laubscher, Prof. Etheresia Pretorius, and Professor Douglas Kell.
To learn more, visit www.medhelpclinics.com
Interested in Becoming A Patient?
Find out if working with Gordon Medical is right for you. Set up a complimentary discovery call with our new patient coordinator at www.gordonmedical.com.
** This information is not to be taken as medical advice. Always consult your practitioner before making any changes to your treatment.
12 episodes
Share
